These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2951476)

  • 1. Protective effect of 4,6-O-ethylidene glucose against the cytotoxicity of streptozotocin in pancreatic beta cells in vivo: indirect evidence for the presence of a glucose transporter in beta cells.
    Kawada J; Okita M; Nishida M; Yoshimura Y; Toyooka K; Kubota S
    J Endocrinol; 1987 Mar; 112(3):375-8. PubMed ID: 2951476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethylidene glucose-substituted new analogue of streptozotocin cannot induce diabetes: study on the basis of structure and activity relationship.
    Kawada J; Okita M; Nukatsuka M; Toyooka K; Naito S; Nabeshima A; Tsujihara K; Yoshimura Y; Nishida M
    Mol Cell Endocrinol; 1989 Apr; 62(2):153-9. PubMed ID: 2526036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta-cells with 5-thio-D-glucose.
    Wang Z; Gleichmann H
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():83-97. PubMed ID: 8839260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
    Wang Z; Gleichmann H
    Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
    Masiello P; Cubeddu TL; Frosina G; Bergamini E
    Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
    Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
    Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazoxide infusion at excess but not at basal hyperglycemia enhances beta-cell sensitivity to glucose in vitro in neonatally streptozotocin-diabetic rats.
    Sako Y; Grill VE
    Metabolism; 1992 Jul; 41(7):738-43. PubMed ID: 1535679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production.
    Katakam AK; Chipitsyna G; Gong Q; Vancha AR; Gabbeta J; Arafat HA
    J Endocrinol; 2005 Nov; 187(2):237-47. PubMed ID: 16293771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of ionizing radiation on the resistance of rat pancreatic beta cells to streptozotocin].
    Gatsko GG; Brilevskaia SI
    Radiobiologiia; 1993; 33(2):225-8. PubMed ID: 8502739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice expressing Shb adaptor protein under the control of rat insulin promoter exhibit altered viability of pancreatic islet cells.
    Welsh M; Christmansson L; Karlsson T; Sandler S; Welsh N
    Mol Med; 1999 Mar; 5(3):169-80. PubMed ID: 10404514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previous adaptation to a high-protein diet protects against streptozotocin-induced inhibition of insulin release from isolated rat islets.
    Eizirik DL; Boschero AC; Migliorini RH
    Braz J Med Biol Res; 1985; 18(2):233-5. PubMed ID: 2937500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose cycling in islets from healthy and diabetic rats.
    Khan A; Chandramouli V; Ostenson CG; Löw H; Landau BR; Efendić S
    Diabetes; 1990 Apr; 39(4):456-9. PubMed ID: 2180757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells.
    Kawada J; Toide K; Nishida M; Yoshimura Y; Tsujihara K
    Diabetes; 1986 Jan; 35(1):74-7. PubMed ID: 2934286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
    Hassan N; Janjua MZ
    J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of high- and low-dose STZ-induced diabetes with D-glucose and 5-thio-D-glucose.
    Wang Z; Dohle C; Friemann J; Green BS; Gleichmann H
    Diabetes; 1993 Mar; 42(3):420-8. PubMed ID: 8432413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.
    Dachicourt N; Serradas P; Bailbé D; Kergoat M; Doaré L; Portha B
    J Endocrinol; 1997 Nov; 155(2):369-76. PubMed ID: 9415071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.